Non-invasive estimation of the net influx constant using the standardized uptake value for quantification of FDG uptake of tumours

European Journal of Nuclear Medicine

Volumn 25, Issue 6, 1998, Pages 559-564

  Sadato, Norihiro ^a   Tsuchida, Tatsuro ^a   Nakaumra, Satoshi ^a   Waki, Atsuo ^a   Uematsu, Hidemasa ^a   Takahashi, Norio ^a   Hayashi, Nobushige ^a   Yonekura, Yoshiharu ^a   Ishii, Yasushi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

2 18F fluoro 2 deoxy D glucose; Glucose metabolism; Neoplasms; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE; GLUCOSE;

ADULT; AGED; ARTICLE; BODY SURFACE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC IMAGING; DISTRIBUTION VOLUME; FEMALE; GLUCOSE BLOOD LEVEL; HEAD CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; MALE; MATHEMATICAL PARAMETERS; NECK CANCER; NEOPLASM; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ASSAY; SQUAMOUS CELL CARCINOMA; STANDARDIZATION;

CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031834634     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050256     Document Type: Article

References (35)

1. Warburg O. The metabolism of tumours. London: Constable & Co, 1930.
2. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
3. Hawkins RA, Hoh C, Dahlbom M, et al. PET cancer evaluations with FDG. J Nucl Med 1991; 32: 1555-1558.
4. Hawkins RA, Choi Y, Huang S-C, Messa C, Hoh CK, Phelps ME. Quantitating tumour glucose metabolism with FDG and PET. J Nucl Med 1992; 33: 339-344.
5. Sakamoto H, Nakai Y, Ohashi Y, Okamura T, Ochi H. Positron emission tomographic imaging of head and neck lesions. Eur Arch Otorhinolaryngol Suppl 1997; 1: S123-126.
6. Benchaou M, Lehmann W, Slosman DO, et al. The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol (Stockh) 1996; 116: 332-335.
7. 18F-fluorodeoxyglucose single-photon emission computed tomography. Am J Roentgenol 1997; 168: 771-774.
8. Lee VS, Martinez S, Coleman RE. Primary muscle lymphoma: clinical and imaging findings. Radiology 1997; 203: 237-244.
9. 18F]fluorodeoxyglucose. Ann Surg Oncol 1997; 4: 57-63.
10. 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases. Stereotact Funct Neurosurg 1996; 66 Suppl 1: 214-224.
11. 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 1997; 168: 1357-1360.
12. Reinhardt MJ, Kubota K, Yamada S, Iwata R, Yaegashi H. Assessment of cancer recurrence in residual tumours after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997; 38: 280-287.
13. Hoh CK, Glaspy J, Rosen P, et al. Whole-body FDG PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 1997; 38: 343-348.
14. Adler LP, Faulhaber PF, Schnur KC, Al-Kasi NL, Shenk RR. Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 1997; 203: 323-327.
15. Utech CI, Young CS, Winter PF. Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med 1996; 23: 1588-1593.
16. 18F-fluorodeoxyglucose positron emission tomography. Am J Roentgenol 1997; 168: 417-424.
17. Bury T, Paulus P, Dowlati A, et al. Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer. Eur Respir J 1996; 9: 2560-2564.
18. Bury T, Dowlati A, Paulus P, Hustinx R, Radermecker M, Rigo P. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography. Eur J Nucl Med 1996; 23: 204-206.
19. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997; 202: 441-446.
20. Damian DL, Fulham MJ, Thompson E, Thompson JF. Positron emission tomography in the detection and management of metastatic melanoma. Melanoma Res 1996; 6: 325-329.
21. Wagner JD, Schauwecker D, Hutchins G, Coleman J Jr. Initial assessment of positron emission tomography for detection of nonpalpable regional lymphatic metastases in melanoma. J Surg Oncol 1997; 64: 181-189.
22. 18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma. Cancer 1997; 79: 695-699.
23. 18F]fluoro-2-deoxy-D-glucose in the low-grade glioma. Neurosurgery 1996; 39: 470-476.
24. Barker FG, Chang SM, Valk PE, Pounds TR, Prados MD. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 1997; 79: 115-126.
25. Keyes JW. SUV: standard uptake or silly useless value. J Nucl Med 1995; 36: 1836-1839.
26. Patlak CS, Blasberg RG. Graphical evaluation of blood-to-brain transfer constants from multiple-time-uptake data: generalization. J Cereb Blood Flow Metab 1985; 5: 584-590.
27. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
28. Thie JA. Clarification of a fractional uptake concept. J Nucl Med 1995; 36: 711-712.
29. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
30. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM Performance characteristics of a whole-body PET scanner. J Nucl Med 1994; 35: 1398-1406.
31. Kim CK, Gupta NC, Chandramouli B, Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med 1994; 35: 164-167.
32. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189: 847-850.
33. Eastman RC, Carson RE, Gordon MR, et al. Brain glucose metabolism in noninsulin-dependent diabetes mellitus: a study in Pima Indians using positron emission tomography during hyperinsulinemia with euglycemic glucose clamp. J Clin Endocrinol Metab 1990; 71: 1602-1610.
34. Wahl RL, Henry CA, Ethier SP. Serum glucose: effects on tumour and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 1992; 183: 643-647.
35. Zasadny KR, Kison PV, Neuhoff A, Wahl RL. Comparison of the influx-constant for FDG as determined from 30-minute and 60-minute dynamic PET scans in patients with lung cancer. J Nucl Med 1997; 38: 244P.